The American Academy of Ophthalmology has announced the appointment of Dr. Russell N. Van Gelder, as Editor-in-Chief of its flagship journal, Ophthalmology, the most widely read clinical publication within the medical specialty of ophthalmology. Dr. Van Gelder is a renowned scientist, prolific author, and esteemed editor who has served as an editorial board member for Ophthalmology, Ophthalmology Retina and Ophthalmology Science, and as a member of the journal’s Editorial Advisory Board.
Dr. Van Gelder is the chair of the University of Washington department of ophthalmology in Seattle, director of the Roger and Angie Karalis Johnson Retina Center, and holder of the Boyd K. Bucey Memorial endowed chair.
Dr. Van Gelder’s laboratory, continuously funded by the National Institutes of Health since 1999, has been at the forefront of research in non-visual photoreception and pathogen detection in uveitis. Non-visual photoreception is an unconventional kind of light-sensitivity sometimes described as sensing light without sight. His team is also investigating an exciting approach to reversing blindness from outer retinal degeneration that involves photoswitch chemicals that can be modulated by visible light.
Ophthalmology®, the official journal of the American Academy of Ophthalmology, publishes original, peer-reviewed, clinically applicable research. The Ophthalmology franchise, owned by the Academy and published by Elsevier, also includes subspecialty publications: Ophthalmology® Retina, Ophthalmology® Glaucoma, and Ophthalmology Science.
Click here to read the original press release.
